Progress in Molecular Biology and Translational Science, Volume 159, provides the most topical, informative and exciting monographs available on a wide variety of research topics related to prions, viruses, bacteria and eukaryotes. The series includes in-depth knowledge on molecular biological aspects of organismal physiology, along with insights on how this knowledge may be applied to understand and ameliorate human disease. New chapters in this release discuss timely topics, such as Targeting recently deorphanized GPR83 for the treatment of infection, stress, and drug addiction, Arrestin Structure-Function, Arrestins in the Cardiovascular System, Analysis of biased agonism, and more.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xi 7. Chapter One: Targeting the Recently Deorphanized Receptor GPR83 for the Treatment of Immunological, Neuroendocrine and Neuropsychiatric Disorders - p. xii 8. Chapter Two: Arrestins in the Cardiovascular System: An Update - p. 25 9. Chapter Three: Global Aquatic Hazard Assessment of Ciprofloxacin: Exceedances of Antibiotic Resistance Development and Ecotoxicological Thresholds - p. 57 10. Chapter Four: Group I Intron-Based Therapeutics Through Trans-Splicing Reaction - p. 77 11. Chapter Five: Major 3′–5′ Exoribonucleases in the Metabolism of Coding and Non-coding RNA - p. 100 12. Chapter Six: Different Methods of Delivering CRISPR/Cas9 Into Cells - p. 155 13. Chapter Seven: Structural Simplicity and Mechanistic Complexity in the Hammerhead Ribozyme - p. 176 14. Index - p. 203
Progress in Molecular Biology and Translational Science, Volume 159, provides the most topical, informative and exciting monographs available on a wide variety of research topics related to prions, viruses, bacteria and eukaryotes. The series includes in-depth knowledge on molecular biological aspects of organismal physiology, along with insights on how this knowledge may be applied to understand and ameliorate human disease. New chapters in this release discuss timely topics, such as Targeting recently deorphanized GPR83 for the treatment of infection, stress, and drug addiction, Arrestin Structure-Function, Arrestins in the Cardiovascular System, Analysis of biased agonism, and more.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xi 7. Chapter One: Targeting the Recently Deorphanized Receptor GPR83 for the Treatment of Immunological, Neuroendocrine and Neuropsychiatric Disorders - p. xii 8. Chapter Two: Arrestins in the Cardiovascular System: An Update - p. 25 9. Chapter Three: Global Aquatic Hazard Assessment of Ciprofloxacin: Exceedances of Antibiotic Resistance Development and Ecotoxicological Thresholds - p. 57 10. Chapter Four: Group I Intron-Based Therapeutics Through Trans-Splicing Reaction - p. 77 11. Chapter Five: Major 3′–5′ Exoribonucleases in the Metabolism of Coding and Non-coding RNA - p. 100 12. Chapter Six: Different Methods of Delivering CRISPR/Cas9 Into Cells - p. 155 13. Chapter Seven: Structural Simplicity and Mechanistic Complexity in the Hammerhead Ribozyme - p. 176 14. Index - p. 203
